Allergen Specific Immunotherapy Articles & Analysis
6 news found
It can be treated by allergen-specific immunotherapy (AIT). Natural allergen extracts do not meet the regulatory requirements for the production of allergy vaccines, the allergens are unstable, the number of allergens varies, pollution, and immunogenicity is poor. Recombinant ...
Symptomatic treatment, at a global cost of over $25 billion yearly, keeps symptoms at bay temporarily but does not offer a long-term solution. Allergen-specific immunotherapy is the only treatment method that targets the root cause of allergies, consistently exposing the allergy sufferer's immune system to sufficient amounts of ...
"I look forward to taking Allovate's lead product, Allerdent®, a proprietary toothpaste base for allergen delivery, to its next level. We have excellent patient feedback that receiving immunotherapy while tooth brushing is a preferred, sustainable model. ...
” The issuing patent including claims to the approach of combining allergenic proteins with toothpaste. These claims provide patent protection for the oral mucosal immunotherapy (OMIT) platform. ...
With consistent use, allergy immunotherapy has been shown to significantly reduce or eliminate the body's allergic responses to pollen, animal dander, dust, insects and other allergens. ...
Allovate, LLC is a specialty biopharmaceutical company that specializes in allergen-specific immunotherapy for treating allergic diseases. Under the agreement, Restore Health has limited exclusivity as the sole servicing agent for Allerdent™. ...